Verint Reports 33% EPS Drop in Fiscal Q2

Verint Systems reported mixed Q2 FY2026 results, with Non-GAAP diluted EPS falling 32.7% to $0.33 and GAAP revenue declining 1.0% to $208 million. While Subscription Annual Recurring Revenue (ARR) grew 6.4% to $728 million, driven by robust 21.2% AI ARR growth, overall profitability was pressured, as non-GAAP operating margin dropped to 14.0% amid elevated R&D spend. Despite this, the company generated positive free cash flow of $13.5 million. Management withheld all financial guidance due to its pending acquisition by Thoma Bravo, significantly limiting forward visibility for investors.

Analysis

Verint Systems (VRNT) reported a challenging second quarter, characterized by a strategic pivot towards AI that has yet to offset declines in its core business and profitability. While AI Annual Recurring Revenue (ARR) demonstrated robust growth of 21.2% to $372 million, and overall subscription ARR rose 6.4%, this was insufficient to prevent a 1.0% year-over-year decline in total GAAP revenue to $208 million. Profitability metrics were notably weak, with non-GAAP diluted EPS falling 32.7% to $0.33 and the non-GAAP operating margin contracting sharply by 710 basis points to 14.0%, reflecting both a 5.6% drop in non-AI subscription ARR and higher R&D expenses. A significant positive was the generation of $13.5 million in free cash flow, a stark reversal from a $3.6 million burn in the prior-year quarter. However, the investment narrative is currently dominated by the pending acquisition by Thoma Bravo, which prompted management to suspend all financial guidance and cancel its earnings call, creating a significant information vacuum and limiting forward visibility for investors.

Key Decisions for Investors

• Recognize that Verint's equity is now primarily an M&A arbitrage play, where the outcome and timeline of the pending Thoma Bravo acquisition are more critical drivers than near-term operating results.
• Given the sharp contraction in operating margins to 14.0% and the 32.7% drop in non-GAAP EPS, investors should exercise caution, as the underlying business fundamentals are deteriorating despite strong AI-related growth.
• Without management guidance, investors must closely monitor the growth trajectory of AI ARR to determine if it can eventually outpace the decline in legacy revenue and stabilize profitability, which is the key variable for the company's long-term standalone value.
• Note the positive free cash flow of $13.5 million as a sign of underlying operational health, but weigh it against the increased net debt and the uncertainty surrounding future capital allocation post-acquisition.